TriSalus Life Sciences, Inc.
The company is researching and developing treatments for liver and pancreatic tumors by integrating novel delivery technologies with immunotherapy. The company is combining its proprietary drug delivery technology with clinical-stage immunotherapy to address immune dysfunction in liver and pancreatic tumors. The FDA-approved device is designed to deliver higher therapeutic doses to tumors with regulated pressure and flow. Delaware-based
Overview
Overview | |
|---|---|
Country | United States |
State | Colorado |
Employees | 101 |
Founded | 2010 |
Financials | |
|---|---|
Market Capitalization | 158.06M |
Revenue | 21.98M |
Operating Income | -56.08M |
Operating Margin | -255.08% |
Net Income | -63.99M |
Ranking
Revenue
Revenue Ranking | |
|---|---|
All | 4137 / 4916 |
Sector : Healthcare | 530 / 851 |
Industry : Medical Devices | 96 / 141 |
Operating Income
Operating Income Ranking | |
|---|---|
All | 4523 / 5373 |
Sector : Healthcare | 746 / 1144 |
Industry : Medical Devices | 119 / 149 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 3788 / 5565 |
Sector : Healthcare | 631 / 1182 |
Industry : Medical Devices | 80 / 150 |
Net Income
Net Income Ranking | |
|---|---|
All | 4496 / 5436 |
Sector : Healthcare | 783 / 1164 |
Industry : Medical Devices | 125 / 149 |
Employees
Employees Ranking | |
|---|---|
All | 4018 / 5330 |
Sector : Healthcare | 636 / 1174 |
Industry : Medical Devices | 104 / 148 |